Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02765854
Title Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University

multiple myeloma


Dexamethasone + Ixazomib + Lenalidomide

Dexamethasone + Ixazomib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.